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Abstract
Although L-3,4-dihydroxyphenylalanine (L-DOPA) is claimed to be a neurotransmitter in the central nervous system
(CNS), receptor or transporter molecules for L-DOPA have not been determined. In an attempt to identify a transporter for
L-DOPA, we examined whether or not an active and high affinity L-DOPA transport system is expressed in Xenopus laevis
oocytes injected with poly A RNA prepared from several tissues. Among the poly A RNAs tested, rabbit intestinal
epithelium poly A RNA gave the highest transport activity for L-[14C]DOPA in the oocytes. The uptake was approximately
five times higher than that of water-injected oocytes, and was partially Na-dependent. L-Tyrosine, L-phenylalanine,
L-leucine and L-lysine inhibited this transport activity, whereas D-DOPA, dopamine, glutamate and L-DOPA cyclohexylester,
an L-DOPA antagonist did not affect this transport. Coinjection of an antisense cRNA, as well as oligonucleotide
complementary to rabbit rBAT (NBAT) cDNA almost completely inhibited the uptake of L-[14C]DOPA in the oocytes. On
the other hand, an antisense cRNA of rabbit 4F2hc barely affected this L-[14C]DOPA uptake activity. rBAT was thus
responsible for the L-[14C]DOPA uptake activity expressed in X. laevis oocytes injected with poly A RNA from rabbit
intestinal epithelium. As rBAT is localized at the target regions of L-DOPA in the CNS, rBAT might be one of the
components involved in L-DOPAergic neurotransmission. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
L-3,4-Dihydroxyphenylalanine (L-DOPA) has been
believed to be only a precursor amino acid, that ex-
erts its actions and e¡ects in Parkinson’s disease via
its conversion to dopamine by aromatic L-amino acid
decarboxylase (AADC). We previously proposed
that L-DOPA itself is a neurotransmitter and/or
modulator in the central nervous system (CNS)
[1,2]. This ‘L-DOPA transmitter hypothesis’ is based
on the following ¢ndings: (1) Immunohistochemical
¢ndings suggest the existence of tyrosine hydroxy-
lase- and L-DOPA-positive, but AADC- and dopa-
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mine-negative neurons, which may contain L-DOPA
as an end product in brain areas such as the hypo-
thalamic nuclei and the nucleus tractus solitarii
(NTS) [2]. (2) L-DOPA is released in a transmitter-
like manner from striata and some nuclei in the low-
er brainstem. [2]. (3) L-DOPA produces pre- and
postsynaptic responses, most of which are antago-
nized by L-DOPA antagonists such as L-DOPA
methyl ester [3,4] and L-DOPA cyclohexylester
(DOPA CHE) [5]. For example, microinjection of
L-DOPA into the NTS and caudal ventrolateral me-
dulla (CVLM) or rostral ventrolateral medulla
(RVLM) of the lower brainstem, elicits blood-depres-
sor or pressor responses [2]. (4) L-DOPAergic ago-
nists and antagonists do not interact with catechol-
aminergic [3] and ionotropic glutamate receptors [6]
in radiolabelled-ligand binding assays.
Although above ¢ndings provide criteria for
L-DOPA being a neurotransmitter and/or neuromod-
ulator, speci¢c receptor(s) and transporter(s) for
L-DOPA have not been identi¢ed [1,2]. L-DOPA
has been characterized as a neutral and large amino
acid. At present, candidate transport systems for
L-DOPA may include system B, system B0;, system
b0;, system L and system yL. Regarding neutral
amino acid transport, system B0;, B and yL are
Na-dependent, while system b0; and L are Na-
independent [7]. Recently, hATB0 which is respon-
sible for system B0; amino acid transport has been
cloned due to the homology with the Na/Cl3-de-
pendent transporter family of neurotransmitters [8].
System b0;, system L and system yL require
unique molecules, related to b0; amino acid trans-
porter (rBAT) (NBAT/D2) [9^11] or 4F2 heavy
chain (4F2hc) (CD98) [12,13], which are now clari-
¢ed to be transporter-associated proteins, but not
transporters themselves. 4F2hc forms heterodimers
with transporter units of system L [14^19] and sys-
tem yL [15,20,21]. On the other hand, rBAT cRNA-
injected oocytes show system b0; activity, which
allows Na-independent transport of cystine and
neutral and basic amino acids [22]. Most recently
the rBAT-associated transporters, b0;AT and
BAT1 have been cloned [23,24]. In contrast to the
ubiquitous expression of 4F2hc [25], rBAT is ex-
pressed in a de¢nite subset of neuronal and/or non-
neuronal cells in peripheral and central nervous tis-
sues [26^29].
Neurotransmitter-transporters in plasma mem-
brane rapidly scavenge and reuptake substrates
from the synaptic cleft with high a⁄nity, thus termi-
nating signal transmission. One of the most impor-
tant aspects of these transporters is that they actively
uptake neurotransmitters in a Na-dependent man-
ner, by utilizing the transmembrane Na gradient
generated by Na/K-ATPase. Until now, systems
for Na-dependent L-DOPA transport have not
been well characterized. In the CNS, transports of
L-DOPA in slices of rat cerebral cortex [30] and cul-
tured rat or mouse astrocytes [31] have shown to be
Na-independent, and show transport property of
system L. We previously demonstrated Na-depen-
dent L-DOPA uptake in slices of rat hypothalamus
[3]. In an attempt to identify the transporter for
L-DOPA, we investigated whether or not an active
and high a⁄nity L-DOPA transport system is func-
tionally expressed in Xenopus oocytes by using poly
A RNA from various animal tissues, and further
characterized the transport activity of L-DOPA in
detail.
2. Materials and methods
2.1. Materials
Adult male Wistar rats and adult male New Zea-
land White rabbits were obtained from SLC (Shizuo-
ka, Japan). ISOGEN, an acid guanidinium-phenol-
chloroform reagent, was obtained from Nippongene
(Tokyo, Japan). Oligo(dT)-cellulose type 7 was from
Pharmacia (Uppsala, Sweden). Female Xenopus lae-
vis was obtained from Hamamatsu Jikken Doubutsu
(Shizuoka, Japan). Collagenase type I and gentami-
cin were from Sigma (St. Louis, MO, USA). A mi-
crodispensor was from Drumond (Broomall, PA,
USA). RNA polymerases, RNase inhibitor and
RNA cap analogue were from Stratagene (La Jolla,
CA, USA), Promega (Madison, WI, USA) and Phar-
macia (Uppsala, Sweden), respectively. L-[14C]DOPA
(10.0^11.4 mCi/mmol) was obtained from Amersham
(Buckinghamshire, UK). To prevent possible oxida-
tion of L-[14C]DOPA, ascorbic acid was added to the
solution at a ¢nal concentration of 0.28 mM. The
stock solution was stored at 320‡C. L-DOPA and
D-DOPA were purchased from Nacalai tesque (Kyo-
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to, Japan). L-DOPA CHE [5] was kindly supplied
from Kyowa Hakkou Kogyo (Shizuoka, Japan).
2.2. RNA preparation and microinjection into oocytes
Tissues and organs of adult male Wistar rats and
New Zealand White rabbits were dissected, and the
rabbit intestinal epithelium was torn o¡ using a slide
glass. Total RNA was extracted from these tissues
using ISOGEN. poly A RNA was isolated with
oligo(dT)-cellulose. X. laevis oocytes were treated
with collagenase for 30^60 min at room temperature
in 5 mM HEPES-bu¡ered OR2 solution (pH 7.6)
containing 82.5 mM NaCl, 2 mM KCl, and 1 mM
MgCl2. After additional manual defolliculation, the
oocytes were maintained overnight at 18‡C in 10 mM
HEPES-bu¡ered Barth’s/gentamicin solution (pH
7.4) containing 88 mM NaCl, 1 mM KCl, 0.33
mM Ca(NO3)2, 0.41 mM CaCl2, 0.82 mM MgSO4,
2.4 mM NaHCO3, and 50 Wg/ml gentamicin. Healthy
stage V, VI oocytes were selected and injected with
50 nl of poly A RNA (1.0 Wg/Wl) or water using a
microdispensor. Following incubation at 18‡C for
3 days, transport activity was measured.
2.3. L-DOPA uptake assay
The 4^10 injected oocytes were preincubated at
room temperature for 10 min in 24-well plates ¢lled
with 3 ml of NaCl uptake solution (pH 7.5) contain-
ing 100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM
CaCl2, 10 mM Tris, and 5 mM HEPES^KOH. The
bu¡er was then replaced by 0.5 ml of uptake solution
containing 30^50 WM L-[14C]DOPA, and the oocytes
were incubated at room temperature for 1 h. In Na-
free uptake solution, choline chloride was substituted
for NaCl. Cl3-free uptake solution (pH 7.5) con-
tained 100 mM sodium gluconate, 2 mM potassium
gluconate, 1 mM MgSO4, 1 mM calcium gluconate,
and 5 mM HEPES^KOH. Inhibition studies were
performed by adding the L-DOPA-related com-
pounds and various amino acids to the uptake solu-
tion at a concentration of 1 mM. Following incu-
bation, the oocytes were washed ¢ve times with ice-
cold Na-free solution. Each oocyte was then dis-
solved in 10% sodium dodecyl sulfate, and the radio-
activity was measured using a liquid scintillation
counter.
2.4. PCR ampli¢cation and cRNA synthesis
To obtain rabbit rBAT cRNA, rabbit intestinal
poly A RNA was reverse transcribed by Superscript
Preampli¢cation System (GIBCO BRL, Ont., Cana-
da). Using this product as a template, PCR ampli¢-
cation was carried out with a forward primer con-
taining an EcoRI site and the sequence upstream of
the initiation codon of rabbit rBAT (5P-CAGAATT-
CGAAGACAGGAGGCTCTAGCAGAT-3P) and a
reverse primer containing an XhoI site and the se-
quence downstream of the termination codon (5P-T-
GCTCGAGGTGCCGCGTCTCCGTCCTC-3P) [11].
After the PCR product was subcloned into pBlue-
script SK3, the resulting construct was linearized
with XhoI and the cDNA insert was transcribed us-
ing T3 RNA polymerase, in the presence of RNase
inhibitor and RNA cap analogue as described previ-
ously [6]. The rabbit 4F2hc fragment was obtained
by nested PCR using primers with reference to the
rat 4F2hc sequence [32]. After ¢rst strand DNA was
ampli¢ed by the 3PRACE System (GIBCO BRL)
with the forward primer (5P-CGGAATTCCTGC-
TCTTCTGGCTCGGTTGGC-3P), this product was
ampli¢ed again with the forward primer (5P-GG-
AATTCGTGGTTATCATCGTTCGGGCG-3P) and
the reverse primer (5P-CCACTCGAGAACGCT-
CATTCTGGTCCCAGTG-3P). The rabbit 4F2hc
RT-PCR product of 941 base pairs had 70% identity
with the rat 4F2hc sequence. Capping antisense
cRNAs of rabbit rBAT and 4F2hc were synthesized
with T7 RNA polymerase by use of linearized rBAT/
pBluescript SK3 lacking the 5P-region including the
initiation codon, and linearized 4F2hc/pBluescript
SK3 as a template, respectively.
2.5. Hybrid depletion
Rabbit intestinal poly A RNA (1.0 Wg/Wl) with or
without each antisense cRNA (0.1 Wg/Wl) was dena-
tured at 65‡C for 5 min and left at room temperature
for 5 min before injection. Hybrid depletion by oli-
gonucleotide was performed as described [33]. In
brief, rabbit intestinal poly A RNA (1.0 Wg/Wl) or
rabbit rBAT cRNA (0.01 Wg/Wl) was denatured at
65‡C for 5 min in a 50 mM NaCl solution containing
20 WM of a 20-mer sense (5P-TGCCCAAGGAGGT-
GCTGTTC-3P, corresponding to nucleotides 203^
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222 downstream from the initiation codon of the
rabbit rBAT mRNA sequence), or a 21-mer antisense
oligonucleotide (5P-GAACAGCACCTCCTTGGG-
CAT-3P, complementary to the nucleotide sequence
position 202^222). These oligonucleotides were de-
signed from conserved sequences among rabbit, hu-
man and rat. For annealing, the solution was further
incubated at 42‡C for 30 min prior to injection into
oocytes.
2.6. Statistical analysis
Statistical analyses were performed by one-way
ANOVA with the Tukey^Kramer multiple compar-
ison test or Dunn’s multiple comparison test. The
statistical di¡erence was accepted for P6 0.05.
3. Results
3.1. L-DOPA uptake activity of various tissues in
Xenopus oocyte expression system
We comparatively assayed L-[14C]DOPA uptake
activity in Xenopus oocytes injected with poly A
RNA from several regions of the brain, the rat adre-
nal gland, and from the rabbit small intestinal epi-
thelium (Table 1). Oocytes injected with each poly
A RNA of the brain regions tested showed a sig-
ni¢cant but very small increase in L-DOPA uptake
activity, being approximately 40% higher than those
injected with water. poly A RNA from rabbit small
intestinal epithelium gave the highest L-DOPA up-
take among these RNAs. This uptake activity was
¢ve-fold higher than that of water-injected oocytes.
In the following study, we characterized the L-DOPA
transport activity expressed in Xenopus oocytes in-
jected with poly A RNA from rabbit small intesti-
nal epithelium.
3.2. Ion dependence and kinetics of L-DOPA uptake
in oocytes injected with poly A+ RNA from rabbit
small intestinal epithelium
L-[14C]DOPA uptake in oocytes injected with poly
A RNA from rabbit small intestinal epithelium or
with water was measured in NaCl containing, in
Table 1
L-DOPA uptake activity in Xenopus oocytes injected with water
or poly A RNA from various tissues
Injected poly A RNA L-DOPA uptake (pmol/h/oocyte)
Water 7.2 þ 0.2
Small intestinal epithelium 30.0 þ 2.1***
Cerebellum 9.9 þ 0.4*
Hypothalamus 10.0 þ 0.5*
Cerebral cortex 10.3 þ 0.4**
Brainstem 10.4 þ 0.3**
Adrenal gland 8.5 þ 0.2
poly A RNAs were obtained from rat tissues except for rabbit
small intestinal epithelium. Three days after injection with poly
A RNA or water, uptake activities were measured in NaCl
uptake solution containing 50 WM L-[14C]DOPA. Each value
represents the mean þ S.E.M. (n = 10). *P6 0.05, **P6 0.01,
***P6 0.001, versus water-injected control.
Fig. 1. Ion dependence of L-DOPA uptake into oocytes injected
with rabbit small intestinal epithelium poly A RNA or water.
Oocytes were incubated for 1 h with NaCl (¢lled bars), Na-
free (open bars) and Cl3-free uptake solution (hatched bars)
containing 41.5 WM L-[14C]DOPA. Data are mean þ S.E.M.
(n = 5^7).
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Na-free or in Cl3-free uptake solution (Fig. 1).
L-DOPA uptake activity of water-injected oocytes
under both Na-free and Cl3-free conditions was
suppressed to 10^15% of the activity observed with
NaCl uptake solution. This suggests that the endog-
enous L-DOPA transport in oocytes is Na- and
Cl3-dependent. The uptake of L-DOPA induced by
rabbit small intestinal epithelium poly A RNA in
Na-free medium was approximately 40% of that in
NaCl containing medium. This indicates that the
L-DOPA transport activity is composed of Na-de-
pendent and -independent fractions. On the other
hand, the L-DOPA uptake in Cl3-free medium was
only slightly attenuated by 20%, compared to that in
NaCl containing medium. This decrease is probably
due to the Cl3-dependency of endogenous L-DOPA
transport in native oocytes. It is thus likely that poly
A RNA-induced L-DOPA transport activity is Cl3-
independent.
L-DOPA uptake activities of RNA-injected oo-
cytes were measured in NaCl and Na-free uptake
solution containing various concentrations of
L-[14C]DOPA (Fig. 2). In both NaCl and Na-free
uptake solution, RNA-injected oocytes exhibited sat-
urable L-DOPA transports. Lineweaver^Burk analy-
sis revealed that the Km was 38.4 þ 3.5 WM for NaCl
uptake solution and 60.4 þ 8.7 WM for Na-free up-
take solution, respectively (mean þ S.D.).
3.3. Inhibition study of L-DOPA uptake
To clarify the substrate speci¢city of the L-DOPA
transport, we examined the e¡ects of various com-
pounds on L-DOPA uptake in the rabbit intestinal
RNA-injected oocytes (Figs. 3 and 4). In the pres-
ence of an excess amount of unlabeled L-DOPA,
L-[14C]DOPA uptake was almost completely abol-
ished (Fig. 3). This transport system was stereoselec-
tive, because D-DOPA did not signi¢cantly a¡ect the
uptake of L-[14C]DOPA. Dopamine did not inhibit
the L-DOPA transport, indicating that dopamine
converted from L-DOPA was not a substrate for
the L-DOPA transport system involved. L-DOPA
CHE, a competitive L-DOPA antagonist [5], barely
a¡ected the L-DOPA uptake. This ¢nding further
con¢rms our previous ¢nding that the recognition
site for the competition between L-DOPA and
L-DOPA antagonists such as L-DOPA CHE and
L-DOPA methyl ester, di¡ers from the site of trans-
port of L-DOPA across the plasma membrane [3].
L-Tyrosine, L-phenylalanine, L-leucine and L-lysine
at 1 mM almost completely inhibited the L-DOPA
Fig. 2. Saturable uptake of L-DOPA into oocytes injected with rabbit intestinal epithelium poly A RNA. Oocytes were incubated
with various concentrations of L-[14C]DOPA in the absence (open circles) or presence (closed circles) of Na. Inset shows Lineweaver^
Burk plots for the experiments. Two independent experiments revealed that apparent Km was 38.4 þ 3.5 WM or 60.4 þ 8.7 WM, and
Vmax was 73.6 þ 6.5 pmol/h/oocyte or 55.3 þ 3.5 pmol/h/oocyte, in the presence or absence of Na, respectively. Each point shows
mean þ S.E.M. (n = 5^7).
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uptake with similar potencies, while L-alanine and
L-tryptophan showed only partial inhibition of the
uptake (Fig. 4). L-Proline and L-glutamate had no
e¡ect on the L-DOPA uptake. Methylamino isobuty-
ric acid (MeAIB), a system A substrate [7], did not
a¡ect the L-DOPA uptake. 2-Amino-2-norbornane-
carboxylic acid (BCH), a substrate for system L
and B0; [22] slightly inhibited the L-DOPA uptake
by 20% (Fig. 4). These results indicate that the up-
take of L-DOPA in oocytes injected with poly A
RNA from rabbit intestinal epithelium showed prop-
erties of neutral and basic amino acid transporter(s).
The amino acid transporter systems that are ¢t for
these characteristics include system b0; and system
yL.
3.4. Hybrid depletion of rabbit intestinal poly A+
RNA-induced L-DOPA uptake
rBAT or 4F2hc, when solely expressed in the
X. laevis oocyte system, is known to induce the trans-
port of neutral and basic amino acids via system b0;
or system yL, respectively [22]. We therefore exam-
ined whether or not these molecules are involved in
the L-DOPA uptake activity in oocytes after injection
of rabbit intestinal poly A RNA. Hybrid depletion
of the poly A RNA with an antisense cRNA com-
plementary to rabbit rBAT or 4F2hc was carried out
Fig. 3. Inhibition study of L-DOPA uptake by L-DOPA-related
compounds. L-[14C]DOPA (30 WM) uptake into oocytes injected
with rabbit intestinal epithelium poly A RNA was performed
with 1 mM non-radioactive compounds in the presence (¢lled
bars) or absence (open bars) of Na. L-DOPA uptake was ex-
pressed as a percentage of the control uptake without inhibitor
in the presence of Na. Data are mean þ S.E.M. (n = 6^10).
*P6 0.05, **P6 0.01, versus corresponding control uptake in
the presence or absence of Na, respectively.
Fig. 4. Inhibition study of L-DOPA uptake by amino acids.
L-[14C]DOPA (30 WM) uptake into oocytes injected with intesti-
nal epithelium poly A RNA was performed with 1 mM non-
radioactive compounds in the presence (¢lled bars) or absence
(open bars) of Na. L-DOPA uptake was expressed as in Fig.
3. Data are mean þ S.E.M. (n = 4^10). *P6 0.01, **P6 0.001,
versus corresponding control uptake in the presence or absence
of Na, respectively.
BBAMEM 77837 12-5-00
H. Ishii et al. / Biochimica et Biophysica Acta 1466 (2000) 61^7066
(Fig. 5). The antisense cRNA of rBAT decreased the
poly A RNA-induced L-DOPA uptake to the en-
dogenous L-DOPA uptake level, while that of
4F2hc did not have a signi¢cant e¡ect. We also ob-
served that an antisense oligonucleotide of rBAT
suppressed L-DOPA uptake activities induced by
the injection of rabbit intestinal poly A RNA, but
the sense oligonucleotide had no e¡ect (Fig. 6). We
con¢rmed that rBAT-expressing oocytes exhibited a
14-fold higher L-DOPA uptake activity in compari-
son with water-injected oocytes, and that the anti-
sense but not sense oligonucleotide of rBAT com-
pletely abolished L-DOPA uptake induced by rBAT
cRNA-injection (Fig. 6). These ¢ndings indicate that
rBAT rather than 4F2hc is an essential component
for L-DOPA transport activity observed in oocytes
injected with poly A RNA from rabbit small intes-
tinal epithelium.
4. Discussion
In this study, we demonstrated for the ¢rst time
the Na-dependent and -independent L-DOPA up-
take in X. laevis oocytes injected with poly A
RNA from rabbit intestinal epithelium. Further-
more, rBAT was essentially involved in both the
Na-dependent and -independent L-DOPA uptake,
because hybrid depletion of rBAT almost completely
inhibited the uptake activities expressed in the oo-
cytes.
We examined the L-DOPA uptake activities ex-
pressed by injection of various poly A RNA from
the CNS. Microinjection of rat hypothalamus, cere-
bral cortex, cerebellum and brainstem poly A RNA
into oocytes signi¢cantly increased the uptake of L-
DOPA by approximately 40% of that due to the
endogenous activity. However, these levels of in-
crease in L-DOPA uptake were quite low, and hence
we were unable to characterize the uptake properties
in detail. We then tested rabbit small intestinal epi-
thelium, since amino acid uptake activity is known to
be relatively high in the intestinal epithelium. As ex-
pected, oocytes injected with rabbit intestinal epithe-
lium poly A RNA showed the highest L-DOPA
uptake activity of approximately ¢ve-fold higher
than that of water-injected oocytes, among the tissue
poly A RNAs tested. The L-DOPA transport in the
oocytes showed saturable uptake with a high a⁄nity.
The apparent Km value was comparable to that of
the transporters for the neurotransmitter glutamate
[34]. These data suggest that uptake carrier mole-
cule(s), but not di¡usion across the membrane,
were involved in the L-DOPA transport. The uptake
experiments in the presence or absence of Na re-
Fig. 5. Hybrid depletion of L-DOPA uptake by antisense cRNA
of rabbit rBAT or 4F2hc. Oocytes were injected with rabbit in-
testinal poly A RNA (poly A) or water, with or without an
antisense cRNA (rBAT, 4F2hc). Three days after injection, up-
take of L-[14C]DOPA (50 WM) was determined in the presence
of Na. Data are mean þ S.E.M. (n = 7^10). *P6 0.001, versus
poly A RNA alone.
Fig. 6. Hybrid depletion of L-DOPA uptake by a sense or an
antisense oligonucleotide (ODN) of the rabbit rBAT cDNA se-
quence in oocytes injected with poly A RNA (poly A, left)
or rBAT cRNA (rBAT, right). Three days after injection, up-
take of L-[14C]DOPA (50 WM) was determined in the presence
of Na. Data are mean þ S.E.M. (n = 10). *P6 0.001, versus
corresponding RNA alone.
BBAMEM 77837 12-5-00
H. Ishii et al. / Biochimica et Biophysica Acta 1466 (2000) 61^70 67
vealed that the L-DOPA transport was composed of
Na-dependent and Na-independent fractions. In
the absence of Cl3, the uptake showed a slight de-
crease. This is probably due to a decrease in endog-
enous L-DOPA transport, as we con¢rmed that
L-DOPA transport in native Xenopus oocytes de-
pended upon both Na and Cl3 [7]. The property
of L-DOPA transport expressed by rabbit intestinal
poly A RNA was thus di¡erent from that of endog-
enous Xenopus oocyte L-DOPA transport, and di¡er-
ent from that of Na/Cl3-dependent amine trans-
porters including the dopamine transporter in
plasma membrane. This again suggests that the
L-DOPA transport activity represents uptake of
L-DOPA itself, but not that of dopamine converted
from L-DOPA. Consistently, an excess amount of
dopamine did not inhibit this L-DOPA uptake.
The amino acid transport systems which may be
responsible for L-DOPA transport include system B,
system B0;, system b0;, system yL and system L.
The uptake of L-DOPA was inhibited by neutral ami-
no acids such as L-tyrosine, L-phenylalanine and
L-leucine. The uptake was also inhibited by the basic
amino acid L-lysine, but was not attenuated by the
acidic amino acid glutamate. These data suggest that
the uptake of L-DOPA is mediated via basic as well
as neutral amino acid transporter(s). This property
appears to be di¡erent from that of system B which
catalyzes Na-dependent uptake only for neutral
amino acids [7]. In the present study, BCH, a sub-
strate for system L and system B0; [22], slightly in-
hibited the Na-dependent L-DOPA uptake with in-
testinal poly A RNA by 20%. This inhibition seems
to be attributed to the inhibitory e¡ect of BCH on
system B0; amino acid transport activity in native
Xenopus oocytes [7]. In accordance with this, the
L-DOPA uptake in water-injected oocytes showed
both Na- and Cl3-dependency. These ¢ndings ex-
clude the possibility that system L or system B0; was
responsible for the intestinal L-DOPA uptake ex-
pressed.
In the hybrid depletion study, an antisense cRNA
and antisense oligonucleotide of rBAT almost com-
pletely suppressed the L-DOPA uptake activities to
the levels of the uptake in water-injected oocytes. An
antisense cRNA of 4F2hc, however, had little, if any,
e¡ect on the L-DOPA transport. These ¢ndings in-
dicate that rBAT, rather than 4F2hc, was involved in
the L-DOPA uptake in oocytes injected with rabbit
intestinal poly A RNA. In addition, we con¢rmed
that both rat 4F2hc/yLAT1- and human 4F2hc/
yLAT2-expressing oocytes barely transported
L-DOPA (unpublished observation). It is therefore
unlikely that system yL was responsible for the
L-DOPA transport in this experiment. An essential
role of rBAT in the L-DOPA uptake suggests that
system b0; was responsible for the L-DOPA trans-
port. However, b0; amino acid transport has been
characterized as the system for Na-independent
neutral and basic amino acid transport, and this
property appears to be di¡erent from that of L-
DOPA uptake in the oocytes injected with rabbit
poly A RNA. In this regard, it is noteworthy that
in rBAT-expressing Xenopus oocytes, a partially
Na-dependent transport activity for L-histidine is
observed [35]. It is thus possible that rBAT and
rBAT-associated transporter(s) may also be involved
in the Na-dependent transport of amino acids such
as L-DOPA. Recently, the ¢rst rBAT-associated
transporter molecules, termed b0;AT and BAT1,
have been identi¢ed [23,24]. Heterodimerization of
rBAT and BAT1 results in expression of system
b0; activity. Further studies are required to investi-
gate whether or not rBAT-associated transporters
other than b0;AT and BAT1 are involved in the
L-DOPA transport in oocytes injected with rabbit
intestinal poly A RNA. Do rBAT and rBAT-asso-
ciated transporters play a role in L-DOPAergic sys-
tems? Interestingly, it appears that rBAT expression
[26^28] is localized at the target regions of L-DOPA
in the CNS such as the hypothalamus and the lower
brainstem [2^4].
The highest level of L-DOPA uptake being found
in the small intestinal epithelium may suggest a large
capacity of this tissue for L-DOPA uptake. A recent
clinical study provides evidence that intestinal ab-
sorption of L-DOPA may be an important factor
for therapeutic e⁄cacy and the untoward actions of
L-DOPA in Parkinson’s disease [36]. In fact, repeated
administration of L-DOPA in rats or patients with
Parkinson’s disease signi¢cantly increases the peak
plasma concentration of L-DOPA, which re£ect ac-
celeration of L-DOPA absorption [36]. As the ‘wear-
ing-o¡’ phenomenon is a motor £uctuation that is
closely related to the timing of L-DOPA dose intake,
the peripheral pharmacokinetics of L-DOPA has
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been regarded as an important contributory factor.
Clarifying whether or not the rBAT-involved
L-DOPA transport system in the intestinal epithelium
can be up-regulated with repeated L-DOPA adminis-
tration may provide an insight into molecular mech-
anisms of the untoward actions encountered with
long term L-DOPA therapy in Parkinson’s disease.
In conclusion, using Xenopus oocytes as an expres-
sion system, we have demonstrated that rBAT is re-
sponsible for the high a⁄nity Na-dependent and
-independent L-DOPA uptake shared with basic
and neutral amino acids in rabbit small intestinal
epithelium. To identify rBAT-associated transport-
er(s) involved in this L-DOPA uptake is a subject
for ongoing study.
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